|
|
Volumn 514, Issue 7524, 2014, Pages 535-536
|
|
Call to action
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EBOLA VACCINE;
AFRICA;
CLINICAL TRIAL (TOPIC);
EBOLA HEMORRHAGIC FEVER;
EBOLA VIRUS;
EDITORIAL;
EPIDEMIC;
HUMAN;
INFECTION CONTROL;
MARBURG VIRUS;
NONHUMAN;
PATIENT SAFETY;
SCIENCE;
UGANDAN;
VESICULAR STOMATITIS VIRUS;
ANIMAL;
BAT;
DEVELOPED COUNTRY;
DISEASE CARRIER;
DISEASE OUTBREAKS;
EPIDEMIOLOGY;
FILOVIRIDAE;
HEMORRHAGIC FEVER, EBOLA;
ISOLATION AND PURIFICATION;
LABORATORY;
MEDICAL RESEARCH;
PATHOGENICITY;
PHYSIOLOGY;
STATISTICS AND NUMERICAL DATA;
SUPPLY AND DISTRIBUTION;
SWINE;
TIME;
TRENDS;
VETERINARY;
VIROLOGY;
AFRICA;
ANIMALS;
BIOMEDICAL RESEARCH;
CHIROPTERA;
DEVELOPED COUNTRIES;
DISEASE OUTBREAKS;
DISEASE RESERVOIRS;
EBOLA VACCINES;
FILOVIRIDAE;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
LABORATORIES;
SWINE;
TIME FACTORS;
|
|
EID: 84908403154
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/514535b Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|